睡眠呼吸中止治療

健康的生活型態並提升生命價值

阻塞性睡眠呼吸中止症 (OSA) 影響全球約 15 億成年人。1  阻塞性睡眠呼吸中止症 (OSA) 會增加慢性疾病的風險,包括高血壓、心臟衰竭、心律不整、心臟冠狀動脈疾病、中風、代謝綜合群、第二型糖尿病、抑鬱症、心臟病呼吸衰竭、癌症而縮短壽命。

未經治療的阻塞性睡眠呼吸中止症 (OSA) 會因人際關係減少、白天精神不濟過度嗜睡、造成工作失誤和工作能力降低、引發交通事故以及提高醫療保健成本而損害生活品質。2,3  阻塞性睡眠呼吸中止症 (OSA)初期治療有助於提高生活質量並能夠改善治療效果和減少併發症,避免併發症造成沉重的經濟負擔(估計每年醫療成本約為美金153,477元)。4 

支持遠距醫療監測並提供一系列符合人體工學面罩,智能設計調整供給空氣壓力或流速,可以改善睡眠時間、體驗、舒適度和保持更健康生活方式。

提升壓力調節和面罩舒適度體驗。

自動感測呼吸流量,供應穩定的氣壓,緩解鼻腔阻塞、提供穩定加濕的呼吸環境,以符合人體工學設計貼合臉部輪廓和輕巧面罩設計(無阻塞、不會造成非幽閉恐懼症)提高了用戶的舒適度、體驗和配戴意願。5 

即時獲得回饋並提高滿意度。

雲端上傳和遠距醫療將用戶遠距連接到即時治療反饋、專業建議和支持工具,增加用戶滿意度、信心和對 CPAP 的配戴意願,同時節省就診、交通費用。6 

進一步了解此產品

Reference


  1. Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pépin JL, Peppard PE, Sinha S, Tufik S, Valentine K, Malhotra A. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019 Aug;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5. Epub 2019 Jul 9. PMID: 31300334; PMCID: PMC7007763. 
  2. Arredondo E, Udeani G, Panahi L, Taweesedt PT, Surani S. Obstructive Sleep Apnea in Adults: What Primary Care Physicians Need to Know. Cureus. 2021 Sep 9;13(9):e17843. doi: 10.7759/cureus.17843. PMID: 34660049; PMCID: PMC8501746. 
  3. Knauert M, Naik S, Gillespie MB, Kryger M. Clinical consequences and economic costs of untreated obstructive sleep apnea syndrome. World J Otorhinolaryngol Head Neck Surg. 2015 Sep 8;1(1):17-27. doi: 10.1016/j.wjorl.2015.08.001. PMID: 29204536; PMCID: PMC5698527. 
  4. Streatfeild J, Hillman D, Adams R, Mitchell S, Pezzullo L. Cost-effectiveness of continuous positive airway pressure therapy for obstructive sleep apnea: health care system and societal perspectives. Sleep. 2019 Dec 24;42(12):zsz181. doi: 10.1093/sleep/zsz181. PMID: 31403163. 
  5. Borel JC, Tamisier R, Dias-Domingos S, Sapene M, Martin F, Stach B, Grillet Y, Muir JF, Levy P, Series F, Pepin JL; Scientific Council of The Sleep Registry of the French Federation of Pneumology (OSFP). Type of mask may impact on continuous positive airway pressure adherence in apneic patients. PLoS One. 2013 May 15;8(5):e64382. doi: 10.1371/journal.pone.0064382. PMID: 23691209; PMCID: PMC3654912. 
  6. Isetta V, Negrín MA, Monasterio C, Masa JF, Feu N, Álvarez A, Campos-Rodriguez F, Ruiz C, Abad J, Vázquez-Polo FJ, Farré R, Galdeano M, Lloberes P, Embid C, de la Peña M, Puertas J, Dalmases M, Salord N, Corral J, Jurado B, León C, Egea C, Muñoz A, Parra O, Cambrodi R, Martel-Escobar M, Arqué M, Montserrat JM; SPANISH SLEEP NETWORK. A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial. Thorax. 2015 Nov;70(11):1054-61. doi: 10.1136/thoraxjnl-2015-207032. Epub 2015 Aug 26. PMID: 26310452.